These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 389316)

  • 1. The FDA's regulation and control of antibiotics in the 1950s: the Henry Welch scandal, Félix Martí-Ibáñez, and Charles Pfizer & Co.
    McFadyen RE
    Bull Hist Med; 1979; 53(2):159-69. PubMed ID: 389316
    [No Abstract]   [Full Text] [Related]  

  • 2. Adequate controls for new drugs: good manufacturing practice and the 1938 federal Food, Drug, and Cosmetic Act.
    Cooper DE
    Pharm Hist; 2002; 44(1):12-23. PubMed ID: 12068915
    [No Abstract]   [Full Text] [Related]  

  • 3. The 1941 sulfathiazole disaster and the birth of good manufacturing practices.
    Swann JP
    Pharm Hist; 1999; 41(1):16-25. PubMed ID: 11623769
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibiotics, big business, and consumers. The context of government investigations into the postwar American drug industry.
    Bud R
    Technol Cult; 2005 Apr; 46(2):329-49. PubMed ID: 16116706
    [No Abstract]   [Full Text] [Related]  

  • 5. Johnny's in the basement, mixin' up the medicine. Review of Angell, Avorn, and Daemmrich on the modern pharmaceutical predicament.
    Mirowski P
    Soc Stud Sci; 2007 Apr; 37(2):311-27. PubMed ID: 17645149
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioequivalence: the regulatory career of a pharmaceutical concept.
    Carpenter D; Tobbell DA
    Bull Hist Med; 2011; 85(1):93-131. PubMed ID: 21551918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prohibited or regulated? LSD psychotherapy and the United States Food and Drug Administration.
    Oram M
    Hist Psychiatry; 2016 Sep; 27(3):290-306. PubMed ID: 27194113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Federal Food and Drug Administration in the United States: born and bred in crises.
    Taylor WJ
    Int J Clin Pharmacol; 1973 Apr; 7(2):156-62. PubMed ID: 4581340
    [No Abstract]   [Full Text] [Related]  

  • 9. Invisible monuments and the costs of pharmaceutical regulation: twenty-five years of drug lag debate.
    Daemmrich A
    Pharm Hist; 2003; 45(1):3-17. PubMed ID: 12691078
    [No Abstract]   [Full Text] [Related]  

  • 10. Anton J. Carlson: witness for the prosecution.
    Young JH
    Pharm Hist; 1999; 41(2):47-51. PubMed ID: 11623946
    [No Abstract]   [Full Text] [Related]  

  • 11. The liberal state and the rogue agency: FDA's regulation of drugs for mood disorders, 1950s-1970s.
    Shorter E
    Int J Law Psychiatry; 2008; 31(2):126-35. PubMed ID: 18343498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative drugs: homeopathy, Royal Copeland, and federal drug regulation.
    White Junod S
    Pharm Hist; 2000; 42(1-2):13-35. PubMed ID: 11624552
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug abuse control under FDA, 1938-1968.
    Swann JP
    Public Health Rep; 1997; 112(1):83-6. PubMed ID: 9018295
    [No Abstract]   [Full Text] [Related]  

  • 14. The Atlanta Falcon and Tono-Bungay: dietary supplements as subprime drugs.
    Weissmann G
    FASEB J; 2009 May; 23(5):1279-82. PubMed ID: 19406845
    [No Abstract]   [Full Text] [Related]  

  • 15. An alternative perspective: homeopathic drugs, Royal Copeland, and federal drug regulation.
    Junod SW
    Food Drug Law J; 2000; 55(1):161-83. PubMed ID: 12375600
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibiotics and the social history of the controlled clinical trial, 1950-1970.
    Podolsky SH
    J Hist Med Allied Sci; 2010 Jul; 65(3):327-67. PubMed ID: 20215414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senator Royal Copeland. The medical and political career of a homeopathic physician.
    Davidson JR; Dantas F
    Pharos Alpha Omega Alpha Honor Med Soc; 2008; 71(3):4-10. PubMed ID: 18767595
    [No Abstract]   [Full Text] [Related]  

  • 18. Two centuries of assessing drug risks.
    Avorn J
    N Engl J Med; 2012 Jul; 367(3):193-7. PubMed ID: 22808954
    [No Abstract]   [Full Text] [Related]  

  • 19. Physician-statesmen.
    Schwartz RA; Adler KP
    Pharos Alpha Omega Alpha Honor Med Soc; 2009; ():57-8. PubMed ID: 19266643
    [No Abstract]   [Full Text] [Related]  

  • 20. Governmental oversight of prescribing medications: history of the US Food and Drug Administration and prescriptive authority.
    Plank LS
    J Midwifery Womens Health; 2011; 56(3):198-204. PubMed ID: 21535368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.